MHY219
MHY219 is a potent novel HDAC inhibitor that induces apoptosis and cell cycle arrest in prostate cancer cells, notably upregulating androgen receptor expression. It demonstrates differential cytotoxicity across cell lines (DU145, LNCaP, PC3) and effectively increases histone H3 acetylation while downregulating class I HDACs. This compound is a valuable research tool for studying HDAC biology and cancer mechanisms in vitro.
Product Specifications
CAS Number
1326750-61-1
Smiles
N (C1=CC=C (NC (CCCCCCC (NO) =O) =O) C=C1) C2=CC=CC=C2
Molecular Formula
C20H25N3O3
Molecular Weight
355.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
126786-ML405 100 µL
FGFR1 (Basic Fibroblast Growth Factor Receptor 1, bFGF-R-1, CD331, FGFBR, FGFR-1, FLG, FLJ99988, FLT2, Fms-like Tyrosine Kinase 2, Proto-oncogene c-Fgr) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
NBP3-05900AF700 0.1 mL
Rabbit Polyclonal FcgR4/CD16-2 Antibody [Alexa Fluor 700]
Sign In for Pricing
View Details MBS083152 Inquire
Donkey Cross-Linked C-Terminal Telopeptides of Type I Collagen ELISA Kit
Sign In for Pricing
View Details